Abstract

Despite considerable efforts to improve early detection, and advances in chemotherapy, metastasis remains a major challenge in the clinical management of ovarian cancer. Studies of new murine models are providing novel insights into the pathophysiology of ovarian cancer, but these models are not readily amenable to genetic screens. Genetic analysis of border-cell migration in the Drosophila melanogaster ovary provides clues that will improve our understanding of ovarian cancer metastasis at the molecular level, and also might lead to potential therapeutic targets.

Author affiliations

1. Department of Molecular Therapeutics, University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
2. Department of Biological Chemistry, Johns Hopkins University School of Medicine, Baltimore, Maryland, USA.

Correspondence to: Denise J. Montell² Email: dmontell@jhmi.edu

MORE ARTICLES LIKE THIS

These links to content published by NPG are automatically generated.